Skylands Capital LLC maintained its stake in Agilent Technologies Inc (NYSE:A) during the first quarter, Holdings Channel reports. The institutional investor owned 9,650 shares of the medical research company’s stock at the end of the first quarter. Skylands Capital LLC’s holdings in Agilent Technologies were worth $510,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. FMR LLC raised its position in shares of Agilent Technologies by 11.8% in the fourth quarter. FMR LLC now owns 20,784,414 shares of the medical research company’s stock worth $946,938,000 after buying an additional 2,200,865 shares in the last quarter. State Street Corp raised its position in shares of Agilent Technologies by 4.7% in the fourth quarter. State Street Corp now owns 14,309,907 shares of the medical research company’s stock worth $651,951,000 after buying an additional 648,254 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of Agilent Technologies by 19.7% in the third quarter. Victory Capital Management Inc. now owns 4,794,946 shares of the medical research company’s stock worth $225,794,000 after buying an additional 790,219 shares in the last quarter. Norges Bank purchased a new position in shares of Agilent Technologies during the fourth quarter worth $118,636,000. Finally, Janus Capital Management LLC raised its position in shares of Agilent Technologies by 26.3% in the fourth quarter. Janus Capital Management LLC now owns 2,361,339 shares of the medical research company’s stock worth $107,583,000 after buying an additional 491,803 shares in the last quarter.
Agilent Technologies Inc (NYSE:A) opened at 53.13 on Friday. Agilent Technologies Inc has a 12 month low of $40.26 and a 12 month high of $54.82. The stock has a market cap of $17.12 billion, a P/E ratio of 34.08 and a beta of 1.19. The company’s 50-day moving average price is $52.71 and its 200-day moving average price is $48.37.
Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Tuesday, February 14th. The medical research company reported $0.53 earnings per share for the quarter, topping analysts’ consensus estimates of $0.49 by $0.04. Agilent Technologies had a return on equity of 15.49% and a net margin of 10.99%. The company had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same quarter in the prior year, the company posted $0.46 EPS. The business’s revenue for the quarter was up 3.8% compared to the same quarter last year. Equities analysts forecast that Agilent Technologies Inc will post $2.16 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 26th. Shareholders of record on Tuesday, April 4th will be paid a dividend of $0.132 per share. This represents a $0.53 dividend on an annualized basis and a dividend yield of 0.99%. The ex-dividend date of this dividend is Friday, March 31st. Agilent Technologies’s dividend payout ratio is presently 37.59%.
Several analysts recently commented on the company. Deutsche Bank AG reaffirmed a “buy” rating and set a $58.00 target price (up from $56.00) on shares of Agilent Technologies in a report on Sunday, April 2nd. Jefferies Group LLC reaffirmed a “buy” rating and set a $59.00 target price on shares of Agilent Technologies in a report on Friday, March 17th. Morgan Stanley raised Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $62.00 target price on the stock in a report on Wednesday, March 15th. Zacks Investment Research raised Agilent Technologies from a “sell” rating to a “hold” rating in a report on Friday, February 17th. Finally, Janney Montgomery Scott raised their target price on Agilent Technologies from $55.00 to $60.00 and gave the stock a “buy” rating in a report on Monday, February 13th. Three equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Agilent Technologies has an average rating of “Buy” and an average target price of $53.89.
In other Agilent Technologies news, VP Rodney Gonsalves sold 8,496 shares of the stock in a transaction on Friday, March 10th. The stock was sold at an average price of $52.05, for a total transaction of $442,216.80. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CFO Didier Hirsch sold 22,256 shares of the stock in a transaction on Wednesday, February 1st. The stock was sold at an average price of $49.50, for a total value of $1,101,672.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 84,644 shares of company stock worth $4,306,465.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc and related companies with our FREE daily email newsletter.